Annals of Oncology · 2014 · 57 citations · 12 references
MedicineOncologyPharmacologyCancer PharmacologyChemotherapyOncology PharmacotherapyBreast Cancer PharmacotherapyMalignant NeoplasmsOncology PharmacologyOvarian Cancer PharmacotherapyToxicity ManagementTyrosine Kinase InhibitorsAurora Kinase InhibitionAurora Kinase SignalingMetastatic Breast Cancer TreatmentMetastatic Carcinoma To The BreastNon-small Cell Lung Cancer TherapyNon-small Cell Lung Cancer TreatmentProtein Kinase InhibitorsTyrosine Kinase Inhibitor Therapy
12
New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
E. Eisenhauer, P. Therasse, Jan Bogaerts et al. · European Journal of Cancer · 2008 · 29.5K citations
Optimal two-stage designs for phase II clinical trials
Richard Simon · Controlled Clinical Trials · 1989 · 3.6K citations
Ursula A. Matulonis, Sudarshan Sharma, Michael S. Gordon et al. · Gynecologic Oncology · 2012 · 134 citations
Medicine, Oncology, Pharmacology +16